US Stock MarketDetailed Quotes

NDRA ENDRA Life Sciences

Watchlist
  • 0.2330
  • -0.0244-9.48%
Trading Nov 6 10:20 ET
4.23MMarket Cap-7P/E (TTM)

ENDRA Life Sciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
8.17%-2.08M
14.46%-2.14M
25.22%-9.55M
29.60%-2.17M
19.96%-2.6M
31.98%-2.27M
19.10%-2.51M
-14.81%-12.77M
-16.43%-3.09M
-18.21%-3.25M
Net income from continuing operations
12.83%-2.23M
5.68%-2.78M
23.67%-10.06M
55.63%-1.46M
9.87%-3.1M
28.79%-2.56M
-2.96%-2.94M
-17.34%-13.18M
-5.96%-3.29M
-29.42%-3.44M
Depreciation and amortization
-31.07%50.12K
-21.63%55.68K
17.58%275.45K
-9.62%61.25K
20.24%70.45K
30.59%72.71K
36.05%71.04K
4.39%234.26K
26.27%67.77K
-4.74%58.59K
Change In working capital
217.87%47.18K
-16.39%106.67K
9.99%-923.32K
-648.17%-1.19M
202.59%178.89K
63.92%-40.03K
121.94%127.58K
18.68%-1.03M
-580.19%-159.02K
63.51%-174.38K
-Change in inventory
719.48%138.05K
-155.75%-231.79K
91.46%-116.19K
69.20%-3.28K
--0
94.99%-22.28K
85.96%-90.63K
-95.72%-1.36M
-104.95%-10.64K
-48.24%-259.35K
-Change in prepaid assets
-0.46%-176.92K
-67.72%42.61K
-52.87%167.36K
258.98%124.98K
208.93%86.49K
-177.74%-176.11K
-53.94%132K
137.10%355.13K
53.97%-78.61K
61.88%-79.4K
-Change in payables and accrued expense
-34.14%128.97K
175.15%337.71K
-836.96%-822.26K
-3,524.36%-1.27M
-33.85%130.8K
40.34%195.81K
164.40%122.74K
-77.28%111.58K
6.92%-35.09K
400.80%197.73K
-Change in other current liabilities
-14.58%-42.91K
-14.58%-41.86K
-15.04%-152.23K
-14.91%-39.85K
-15.08%-38.39K
-15.09%-37.45K
-15.08%-36.53K
-31.88%-132.33K
-15.42%-34.68K
-15.61%-33.36K
Cash from discontinued investing activities
Operating cash flow
8.17%-2.08M
14.46%-2.14M
25.22%-9.55M
29.60%-2.17M
19.96%-2.6M
31.98%-2.27M
19.10%-2.51M
-14.81%-12.77M
-16.43%-3.09M
-18.21%-3.25M
Investing cash flow
Cash flow from continuing investing activities
11K
11.87%-23.8K
87.80%-24.72K
105.91%2.28K
0
0
69.78%-27K
-350.17%-202.58K
-38.56K
-14.86K
Net PPE purchase and sale
--11K
11.87%-23.8K
87.80%-24.72K
105.91%2.28K
--0
--0
69.78%-27K
-350.17%-202.58K
---38.56K
---14.86K
Cash from discontinued investing activities
Investing cash flow
--11K
11.87%-23.8K
87.80%-24.72K
105.91%2.28K
--0
--0
69.78%-27K
-350.17%-202.58K
---38.56K
---14.86K
Financing cash flow
Cash flow from continuing financing activities
55.05%7.34M
468.9K
-10.49%7.52M
1.67M
1.11M
-37.28%4.73M
0
-37.32%8.4M
0
0
Net issuance payments of debt
--0
---28.48K
----
----
----
--0
--0
----
----
----
Net common stock issuance
-84.54%728.5K
--419.97K
-22.81%6.48M
--656.81K
--1.11M
-37.54%4.71M
--0
-20.88%8.4M
--0
--0
Proceeds from stock option exercised by employees
32,861.80%6.61M
--77.42K
--1.03M
--1.01M
--0
--20.05K
--0
--0
--0
--0
Cash from discontinued financing activities
Financing cash flow
55.05%7.34M
--468.9K
-10.49%7.52M
--1.67M
--1.11M
-37.28%4.73M
--0
-37.32%8.4M
--0
--0
Net cash flow
Beginning cash position
-51.82%1.13M
-42.04%2.83M
-48.33%4.89M
-58.40%3.33M
-57.27%4.82M
-66.95%2.36M
-48.33%4.89M
30.91%9.46M
-32.03%8.02M
-19.69%11.28M
Current changes in cash
113.70%5.27M
32.94%-1.7M
55.05%-2.06M
83.99%-500.63K
54.47%-1.48M
-40.63%2.46M
-8.55%-2.53M
-304.65%-4.57M
-34.12%-3.13M
-44.95%-3.26M
End cash Position
32.81%6.4M
-51.82%1.13M
-42.04%2.83M
-42.04%2.83M
-58.40%3.33M
-57.27%4.82M
-66.95%2.36M
-48.33%4.89M
-48.33%4.89M
-32.03%8.02M
Free cash flow
8.65%-2.07M
14.31%-2.17M
26.13%-9.58M
30.24%-2.18M
20.32%-2.6M
33.17%-2.27M
20.52%-2.53M
-16.16%-12.97M
-17.89%-3.13M
-18.75%-3.26M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 8.17%-2.08M14.46%-2.14M25.22%-9.55M29.60%-2.17M19.96%-2.6M31.98%-2.27M19.10%-2.51M-14.81%-12.77M-16.43%-3.09M-18.21%-3.25M
Net income from continuing operations 12.83%-2.23M5.68%-2.78M23.67%-10.06M55.63%-1.46M9.87%-3.1M28.79%-2.56M-2.96%-2.94M-17.34%-13.18M-5.96%-3.29M-29.42%-3.44M
Depreciation and amortization -31.07%50.12K-21.63%55.68K17.58%275.45K-9.62%61.25K20.24%70.45K30.59%72.71K36.05%71.04K4.39%234.26K26.27%67.77K-4.74%58.59K
Change In working capital 217.87%47.18K-16.39%106.67K9.99%-923.32K-648.17%-1.19M202.59%178.89K63.92%-40.03K121.94%127.58K18.68%-1.03M-580.19%-159.02K63.51%-174.38K
-Change in inventory 719.48%138.05K-155.75%-231.79K91.46%-116.19K69.20%-3.28K--094.99%-22.28K85.96%-90.63K-95.72%-1.36M-104.95%-10.64K-48.24%-259.35K
-Change in prepaid assets -0.46%-176.92K-67.72%42.61K-52.87%167.36K258.98%124.98K208.93%86.49K-177.74%-176.11K-53.94%132K137.10%355.13K53.97%-78.61K61.88%-79.4K
-Change in payables and accrued expense -34.14%128.97K175.15%337.71K-836.96%-822.26K-3,524.36%-1.27M-33.85%130.8K40.34%195.81K164.40%122.74K-77.28%111.58K6.92%-35.09K400.80%197.73K
-Change in other current liabilities -14.58%-42.91K-14.58%-41.86K-15.04%-152.23K-14.91%-39.85K-15.08%-38.39K-15.09%-37.45K-15.08%-36.53K-31.88%-132.33K-15.42%-34.68K-15.61%-33.36K
Cash from discontinued investing activities
Operating cash flow 8.17%-2.08M14.46%-2.14M25.22%-9.55M29.60%-2.17M19.96%-2.6M31.98%-2.27M19.10%-2.51M-14.81%-12.77M-16.43%-3.09M-18.21%-3.25M
Investing cash flow
Cash flow from continuing investing activities 11K11.87%-23.8K87.80%-24.72K105.91%2.28K0069.78%-27K-350.17%-202.58K-38.56K-14.86K
Net PPE purchase and sale --11K11.87%-23.8K87.80%-24.72K105.91%2.28K--0--069.78%-27K-350.17%-202.58K---38.56K---14.86K
Cash from discontinued investing activities
Investing cash flow --11K11.87%-23.8K87.80%-24.72K105.91%2.28K--0--069.78%-27K-350.17%-202.58K---38.56K---14.86K
Financing cash flow
Cash flow from continuing financing activities 55.05%7.34M468.9K-10.49%7.52M1.67M1.11M-37.28%4.73M0-37.32%8.4M00
Net issuance payments of debt --0---28.48K--------------0--0------------
Net common stock issuance -84.54%728.5K--419.97K-22.81%6.48M--656.81K--1.11M-37.54%4.71M--0-20.88%8.4M--0--0
Proceeds from stock option exercised by employees 32,861.80%6.61M--77.42K--1.03M--1.01M--0--20.05K--0--0--0--0
Cash from discontinued financing activities
Financing cash flow 55.05%7.34M--468.9K-10.49%7.52M--1.67M--1.11M-37.28%4.73M--0-37.32%8.4M--0--0
Net cash flow
Beginning cash position -51.82%1.13M-42.04%2.83M-48.33%4.89M-58.40%3.33M-57.27%4.82M-66.95%2.36M-48.33%4.89M30.91%9.46M-32.03%8.02M-19.69%11.28M
Current changes in cash 113.70%5.27M32.94%-1.7M55.05%-2.06M83.99%-500.63K54.47%-1.48M-40.63%2.46M-8.55%-2.53M-304.65%-4.57M-34.12%-3.13M-44.95%-3.26M
End cash Position 32.81%6.4M-51.82%1.13M-42.04%2.83M-42.04%2.83M-58.40%3.33M-57.27%4.82M-66.95%2.36M-48.33%4.89M-48.33%4.89M-32.03%8.02M
Free cash flow 8.65%-2.07M14.31%-2.17M26.13%-9.58M30.24%-2.18M20.32%-2.6M33.17%-2.27M20.52%-2.53M-16.16%-12.97M-17.89%-3.13M-18.75%-3.26M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data